Another Honor | Gluetacs Wins the Finalist Award at the 4th Biopharma “Rising Star” Competition

ON：2024-11-27 TAGS：GLUETACS THERAPEUTICS

Recently, the “Biopharma Industry Investment and Financing Forum” and the award ceremony for the 4th “Rising Star” Competition were grandly held at the Zhangjiang Science Hall in Shanghai. The event was co-hosted by the Shanghai Center of Biomedicine Development, E Fund Private Equity Management Co., Ltd., and Shanghai State-Owned Capital Investment Co., Ltd. With the theme “Innovation Continues to Evolve, Connecting the Global Ecosystem,” the forum brought together leading domestic and international innovative enterprises, experts, scholars, and financial institutions. Through keynote speeches and high-level discussions, participants delved deeply into the global innovation and development of China’s pharmaceutical industry.

Previously, Gluetacs participated in the 4th “Rising Star” competition. After rigorous selection and intense competition, the company stood out among 129 high-quality projects in the innovative drug field from China and abroad, earning the Finalist Award.

Gluetacs continues to receive recognition through prestigious professional awards, which not only affirm the company’s innovative achievements but also highlight its overall research and development strength and influence in the innovative drug industry. This recognition further motivates Gluetacs to continue advancing the research and development of protein degraders, bringing tangible benefits to patients.